Literature DB >> 1354216

HLA gene analysis in a Japanese family with hypertrophic cardiomyopathy by restriction fragment length polymorphism.

T Kanda1, N Takeuchi, A Hasegawa, T Suzuki, K Murata.   

Abstract

A large Japanese family with hypertrophic cardiomyopathy (HCM) was examined (n = 61). Ten of 14 affected family members who showed HCM on the basis of electrocardiography and two-dimensional echocardiography were subjected to human leukocyte antigen (HL-A)-A,B,C typing by the lymphocyte cytotoxicity test and D, DR typing by restriction fragment length polymorphism (RFLP). As control, the HLA genotype of 14 non-affected family members was analyzed. HLA typing of the affected subjects with HCM revealed a very close association (67%) of HLA-DR (4w8) among A,B,C,D and DR. However, the LOD scores of HLA-DR4 and -DR w8 were 0.693 (theta = 0.35) and 0.642 (theta = 0.30) respectively. These data suggest that HLA-loci, analyzed on the basis of RFLP, may not be related with familial HCM with or without obstruction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354216     DOI: 10.1007/bf01744869

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  12 in total

1.  Genetic tests under incomplete ascertainment.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1959-03       Impact factor: 11.025

2.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

3.  A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene.

Authors:  G Tanigawa; J A Jarcho; S Kass; S D Solomon; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

4.  HLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.

Authors:  S Fiorito; C Autore; P V Fragola; M Purpura; D Cannata; M Sangiorgi
Journal:  Am Heart J       Date:  1986-01       Impact factor: 4.749

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  HLA antigens in idiopathic dilated cardiomyopathy.

Authors:  C J Limas; C Limas
Journal:  Br Heart J       Date:  1989-11

7.  HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.

Authors:  A Matsumori; C Kawai; A Wakabayashi; P I Terasaki; M S Park; T Sakurami; Y Ueno
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

Review 8.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review.

Authors:  E D Wigle; Z Sasson; M A Henderson; T D Ruddy; J Fulop; H Rakowski; W G Williams
Journal:  Prog Cardiovasc Dis       Date:  1985 Jul-Aug       Impact factor: 8.194

9.  Two forms of hypertrophic cardiomyopathy distinguished by inheritance of HLA haplotypes and left ventricular outflow tract obstruction.

Authors:  C Kishimoto; T Kaburagi; S Takayama; S Yokoyama; I Hanyu; Y Takatsu; K Tomimoto
Journal:  Am Heart J       Date:  1983-06       Impact factor: 4.749

10.  Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease.

Authors:  S D Solomon; J A Jarcho; W McKenna; A Geisterfer-Lowrance; R Germain; R Salerni; J G Seidman; C E Seidman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.